首页 | 官方网站   微博 | 高级检索  
     

壳聚糖纳米粒作为消化道给药基因治疗载体的研究
引用本文:郑芳,李雁,施晓文,杨桂芳,龚玲玲,袁宏银,杜予民,崔冶建,汪艳.壳聚糖纳米粒作为消化道给药基因治疗载体的研究[J].中华实验外科杂志,2008,25(6).
作者姓名:郑芳  李雁  施晓文  杨桂芳  龚玲玲  袁宏银  杜予民  崔冶建  汪艳
作者单位:1. 武汉大学中南医院肿瘤科肿瘤生物学行为湖北省重点实验室,430071
2. 武汉大学环境与资源学院
3. 武汉大学生物医学结构中心
基金项目:教育部跨世纪优秀人才培养计划,教育部全国优秀博士学位论文作者专项基金,湖北省杰出青年科学基金 
摘    要:目的 观察壳聚糖纳米粒载体的体内外基因转染活性,寻找最佳转染条件.方法 以编码GFP的质粒DNA作报告基因,3种不同壳聚糖季铵化壳聚糖(TMO-60%),壳聚糖(43×103~45×103,87%),壳聚糖(230×103,90%)]分别与质粒DNA混合,用复凝聚法制备壳聚糖/DNA复合物.检测纳米粒形态和直径,壳聚糖对DNA包裹力,体外转染效率,纳米粒包裹质粒饲喂裸鼠后报告基因在消化道黏膜的表达率.结果 壳聚糖纳米粒能高效稳定包裹质粒DNA;TMO-60%与DNA的比例为3.2∶ 1.0时,体外转染效率最高,达28.9%;TMO-60%/质粒DNA复合物灌胃后,全胃肠道均有GFP表达,尤其在胃和小肠上段最强.结论 季铵化壳聚糖纳米粒在体内、体外均有较高的转染活性,是基因治疗的可取载体.

关 键 词:壳聚糖  纳米粒  基因治疗  胃肠道

Experimental studies on chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration
Abstract:Objective To investigate the in vitro and in vivo gene transfection activity of the chitosan nanoparticle as gene therapy vector.Methods Chitosan nanoparticles integrating plasmid DNA encoding green fluorescent protein (GFP) and three different types of chitosan quaternized chitosan (TMO-60%),C (43×103-45×103,87%),and C (230×103,90%)] were made by complex coacervation process.The shape and size of the particles were studied by transmission electron microscopy.The chitosan-DNA binding capability was detected by gel electrophoresis.The optimal chitosan:DNA ratio for maximal in vitro transfection was studied by adding various chitosan nanoparticles to the cell culture of human hepatocellular carcinoma cell line HCCLM6.The chitosan nanoparticles were fed to 12 BALB/C-nu/nu nude mice via a gastric feeding tube,2 times a week for a month,by the end of which the in vivo transfection efficiency of the gastrointestinal tract mucosa was studied.Negative control and blank control were set up at the same time.Results Both conventional and quaternized chitosan could form stable nanoparticles with plasmid GPF.The in vitro study showed the transfection efficiency was in the following descending order: quaternized chitosan >C (43×103-45×103,87%) >C (230×103,90%).The quaternized chitosan was proved to be the most efficient obvious GFP expression in the whole gastrointestinal tract,particularly in the gastric and upper intestinal mucosa.Conclusion The quaternized chitosan nanoparticle has relatively high in vitro and in vivo transfection activity,with minimal toxicity,which made it a desirable non-viral vector for gene therapy.
Keywords:Chitosan  Nanoparticle  Gene therapy  Gastrointestinal tract
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号